Akari Therapeutics receives European patent for RNA splicing ADC payload May 12, 2026 08:33AM
Akari Therapeutics gets Australian patent for ADC payload technology Apr 27, 2026 08:36AM
Maxim Group Downgrades Akari Therapeutics (AKTX) to Hold Apr 8, 2026 08:01AM
Akari Therapeutics changes ADS ratio to maintain Nasdaq listing Mar 17, 2026 04:30PM
AKTX advances lead cancer drug candidate toward clinical trials Mar 13, 2026 09:16AM


Dec 30, 2025 09:15AM Akari Therapeutics outlines 2025 progress in shareholder letter
Dec 9, 2025 08:40AM Akari Therapeutics reports preclinical data for pancreatic cancer drug
Nov 17, 2025 04:59PM Akari Therapeutcis (AKTX) files for 6.375M share ADSs offering by selling stockholders
Nov 10, 2025 08:32AM Akari Therapeutics reports preclinical data on novel ADC payload
Oct 22, 2025 09:05AM Akari Therapeutics launches CEO Corner communication platform
Oct 9, 2025 08:46AM Akari Therapeutics files two patents for cancer drug platform
Sep 24, 2025 08:46AM Akari Therapeutics reports preclinical data on prostate cancer payload
Sep 17, 2025 08:45AM AKARI Therapeutics files patent for cancer ADC platform
Sep 9, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)
Jul 23, 2025 08:55AM Akari Therapeutics advances research on cancer drug payload PH1
Jul 22, 2025 08:40AM JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Jul 18, 2025 08:22AM Maxim Group Starts Akari Therapeutics (AKTX) at Buy
Jun 18, 2025 08:50AM Akari Therapeutcis (AKTX) Granted Patent Protection Across India
May 15, 2025 05:01PM Akari Therapeutcis (AKTX) Reports In-Line Q1 EPS
May 1, 2025 08:48AM Akari Therapeutcis (AKTX) Appoints Mark F. Kubik as Head of Business Development - Oncology
Mar 20, 2025 08:35AM Akari Therapeutcis (AKTX) Appoints Abizer Gaslightwala as CEO and President
Mar 3, 2025 09:02AM Akari Therapeutcis (AKTX) Announces $7.6M Private Placement
Dec 18, 2024 08:53AM Akari Therapeutics (AKTX) Announces Key Leadership Appointments
Dec 16, 2024 09:06AM Akari Therapeutcis (AKTX) Appoints Torsten Hombeck as CFO
Nov 19, 2024 08:02AM Akari Therapeutcis (AKTX) Regains Nasdaq Compliance
Nov 8, 2024 08:00AM Akari Therapeutcis (AKTX) Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
Sep 17, 2024 08:01AM Akari Therapeutcis (AKTX): Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics